What's Happening?
The U.S. Department of Agriculture (USDA) has awarded $2 million to a research team led by Purdue University to evaluate a novel antiviral fogging technology aimed at combating high pathogenic avian influenza (HPAI). The project involves using hydrogenated
catmint oil (HCO) to target and inhibit the virus in poultry environments. The technology is designed to be deployed through fogging systems in commercial poultry and egg houses, where airborne virus transmission is a major driver of outbreaks. The research will assess HCO's antiviral effects in the lab, its safety in chickens, and its effectiveness in real-world poultry housing conditions.
Why It's Important?
Avian influenza outbreaks have led to significant economic losses and supply disruptions in the U.S. poultry industry, with more than 90 million poultry lost since 2022. The development of effective antiviral technologies is crucial for enhancing biosecurity and reducing the impact of HPAI outbreaks. This project represents a significant step forward in controlling avian influenza and advancing innovative solutions for animal health, potentially providing poultry producers with a cost-effective biosecurity tool.
What's Next?
The project will involve controlled trials at Purdue University to measure the effectiveness of aerosolized HCO in reducing avian influenza virus titers in air, on surfaces, and in birds. Ohio State University will assist with efficacy testing against highly pathogenic strains using specialized BSL-3 laboratory facilities. If successful, the research could provide poultry producers with a breakthrough biosecurity tool designed to reduce airborne viral transmission inside commercial poultry and egg facilities.
